ED Visit Volume Dropped for Mental Health, Substance Use Early in Pandemic
WEDNESDAY, Feb. 17, 2021 -- Emergency department visits for mental health, substance use, and violence decreased in the early days of the COVID-19 pandemic, according to a study published online Feb. 3 in JAMA Psychiatry.
Kristin M. Holland, Ph.D., M.P.H., from the U.S. Centers for Disease Control and Prevention in Atlanta, and colleagues examined changes in U.S. emergency department visits for mental health conditions, suicide attempts, overdose (all drugs and opioids), and violence outcomes (intimate partner violence and suspected child abuse and neglect) for Dec. 30, 2018, to Oct. 10, 2020. A total of 187,508,065 total emergency department visits were captured; at least one study outcome was captured in 6,018,318 visits.
The researchers found that after implementation of COVID-19 mitigation measures beginning March 16, 2020, total emergency department visit volume decreased. Between March 8 and 28, 2020, weekly emergency department visit counts for all six outcomes decreased. However, beginning the week of March 22 to 28, emergency department visit rates increased. The 2020 counts were significantly higher for suicide attempts, all overdoses, and opioid overdoses when comparing the median emergency department visit counts between March 15 and Oct. 10, 2020, with the same period in 2019. Counts were significantly lower for intimate partner violence emergency department visits and suspected child abuse and neglect visits. During the same period, median rates were significantly higher in 2020 versus 2019 for all outcomes except intimate partner violence.
"Past research on public health crises suggests it is likely that COVID-19 and associated mitigation measures will have impacts that far outlast the short-term emergency period," the authors write.
© 2021 HealthDay. All rights reserved.
Posted: February 2021
Further Support and Information on COVID-19
Read this next
FRIDAY, March 5, 2021 -- Psychiatric visits increased significantly during 2020 compared with 2019, but there was a decrease in new patients seeking care, according to a study...
THURSDAY, March 4, 2021 -- Cardiovascular risk factors are associated with cognitive impairment among individuals with schizophrenia, according to a review and meta-analysis...
WEDNESDAY, March 3, 2021 -- Discordance between patient and physician assessments of psoriasis severity is associated with patient depression and anxiety, according to a study...
More News Resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our Newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.